Article Figures & Data
Figures
- Figure 1.
L-selectin as a Potential Biomarker for PML Risk
MS, multiple sclerosis; PML, progressive multifocal leukoencephalopathy.
Schwab N et al. Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients. Neurology. 2013;81:865–871.
Tools
Potential Biomarkers for Identification of PML in MS
Permalink:
